Evaluation of frxA and rdxA gene mutations in clinical metronidazole resistance Helicobacter pylori isolates
Evaluation of frxA and rdxA gene mutations in clinical metronidazole resistance Helicobacter pylori isolates
نویسندگان: محمد حسین صومی , محمد رحمتی , طیبه کفشدوزپور پلسنگی , مرتضی میلانی
کلمات کلیدی: Helicobacter pylori, Metronidazole resistance, rdxA, frxA
نشریه: 55487 , 2 , 34 , 2017
| نویسنده ثبت کننده مقاله |
مرتضی میلانی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
بیماری های گوارش و کبد |
| کد مقاله |
60852 |
| عنوان فارسی مقاله |
Evaluation of frxA and rdxA gene mutations in clinical metronidazole resistance Helicobacter pylori isolates |
| عنوان لاتین مقاله |
Evaluation of frxA and rdxA gene mutations in clinical metronidazole resistance Helicobacter pylori isolates |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
http://msptm.org/journal-vol-34-no-2/ |
| Abstract. Metronidazole resistance is an important factor related to failure in the treatment
of Helicobacter pylori. The mutation in the rdxA and frxA genes is the most important cause
of resistance to metronidazole. Since the resistance rate of metronidazole is high in our
region, we decided to assess the frequency of these mutations among H. pyloriclinical
isolates. Antral gastric biopsy specimens were cultured and minimal inhibitory concentrations
(MICs) of metronidazole were determined by the E-test method. The rdxA and frxA genes
were amplified in all isolates through the use of PCR with the specific primers. PCR products
were purified for sequencing. The resultant sequences were compared with the wild type
reference sequences to find any possible mutations. According to our findings, the rate of
metronidazole resistance was 77%, with the MICs ranging from 0.25-1 µg/ml for metronidazolesensitive group and from 16-256 µg/ml for resistance group. H. pyloriisolates containing a
single mutation in rdxA or frxA genes demonstrated a low MIC (8-16 µg/ml), while those
containing mutations in both genes showed a higher MIC (32-256 µg/ml). In this study, all
resistant H. pyloriisolates contained single or multiple nucleotide substitutions in the
mentioned genes. Nevertheless, no nucleotide substitutions were found in the sensitive
clinical isolates. The results of our study showed that the mutations in rdxA are mostly
related to metronidazole resistance, and mutations in frxA are able to enhance H. pylori
resistance. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 346-351-Milani-M.pdf | 1396/03/24 | 50044 | دانلود |